Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

(NasdaqGM:FULC), ― Clear dose-response observed, with a robust and clinically meaningful fetal hemoglobin (HbF) induction at the Week 6 timepoint (n=12): mean absolute HbF in the 20 mg cohort increased by 9.9% at Week 6 (vs. 5.6% at Week 6 in the 12 mg cohort); 7 of 12 patients in the 20 mg cohort (58%) […]

TScan Therapeutics Announces Positive Updated Data from the ALLOHA(TM) Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics Announces Positive Updated Data from the ALLOHA(TM) Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition GlobeNewswire December 06, 2025 Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23) and overall survival (HR=0.61; p=0.52) 3/3 (100%) of TSC-101-treated patients who reached two-year follow-up remained relapse-free vs.

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting GlobeNewswire December 06, 2025 ― Clear dose-response observed, with a robust and clinically meaningful fetal hemoglobin (HbF) induction at the Week 6

MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users

New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition. MENU – ORDER AI, the first real-time GLP-1 dining companion designed to guide users toward High-protein and GLP-1 friendly meal choices, announced that the app now supports a growing international audience with multilingual capabilities. Users can now

ROSEN, A LEADING LAW FIRM, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRGO

New York, New York–(Newsfile Corp. – December 6, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline. SO WHAT:

Discount Tire Celebrates Inter Miami CF MLS Cup Championship

Leading tire retailer sponsors Inter Miami CF during 2025 MLS season resulting in Philip F. Anschutz Trophy Discount Tire, a leading retailer of tires and wheels, is celebrating the Major League Soccer Cup victory by Inter Miami CF, which Discount Tire has sponsored since 2024. Inter Miami beat the Vancouver Whitecaps FC at Chase Stadium

ROSEN, A LEADING AND RANKED FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INSP

New York, New York–(Newsfile Corp. – December 6, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO

Resource Growth Programs Gain Momentum as Gold Holds Above $4,200

Issued on behalf of GoldHaven Resource Corp. Equity Insider News Commentary – Gold re-emerged trading above $4,200 per ounce, marking sustained strength in the precious metal as investors maintain safe-haven positions[1]. Drilling programs across multiple jurisdictions are advancing systematic resource expansion efforts, with explorers reporting high-grade intercepts and development milestones throughout November[2]. These conditions create

DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

(NASDAQ:DXCM), NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”) of the important December 29, 2025 lead plaintiff deadline. SO WHAT: If you

DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM GlobeNewswire December 06, 2025 NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of

Scroll to Top